Global Reach

Global footprint with a single site contract

The need for site scalability and speed to recruit and enroll patients has become more evident, especially during the COVID-19 pandemic. High demand for patients with specific conditions or diseases and limited capacity at sites in the United States mean that the need to deploy the right sights across the globe can be crucial to enroll your study. Given that nearly half of research sites under enroll or recruit no patients at all, engaging a partner with a large, global site footprint means you have greater flexibility to identify and select the right sites for your program.  

All AES sites are experienced at executing clinical trials quickly and successfully, even during global pandemics, with some of our largest sites being located outside of the United States. Like sites in the United States, our sites in Europe, Latin America and Africa are purpose-built and used solely for clinical research. Some of the biggest sites in the AES network are outside of the United States. With 12-16 consulting rooms, sites in locations such as Wroclaw and Warsaw, Poland, and Watermeyer in South Africa, for example, offer the same capability to manage large volumes of patients efficiently and cost-effectively to ensure faster study activation. Our sites also feature complete onsite capabilities such as labs, pharmacies and call centers to make study participation easier on patients.